스캐폴드 기술 시장 규모, 점유율, 성장 분석 : 유형별, 소재별, 질환 유형별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Scaffold Technology Market Size, Share, Growth Analysis, By Type (Hydrogels, Polymeric Scaffolds), By Material (Bio-inert, Bioresorbable), By Disease Type, By Application, By End-Use, By Region - Industry Forecast 2025-2032
상품코드:1630725
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 스캐폴드 기술 시장 규모는 2023년에 19억 8,000만 달러로 평가되며, 2024년 22억 5,000만 달러에서 2032년에는 63억 4,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 13.8%로 성장할 전망입니다.
스캐폴드 기술 시장은 장기 이식 및 재건 치료에 대한 전 세계 수요 증가로 인해 장기 기능 부전 환자 증가로 인해 크게 성장하고 있습니다. 조직공학 및 재생의학에서 종종 고분자 바이오소재로 만들어진 스캐폴더는 세포에 필수적인 구조적 지지대를 제공하여 새로운 조직 형성을 촉진합니다. 조직 공학의 세 가지 요소는 세포, 스캐폴더, 성장인자로 구성되며, 스캐폴더는 섬유질, 다공성, 하이드로겔 형태로 분류됩니다. 비계의 성공 여부는 생체 적합성, 기계적 특성, 생분해성 등 중요한 요소에 달려 있습니다. 또한 첨단 3D 매트릭스 개발을 위한 생명공학 기업의 R&D 투자 증가는 시장 발전을 촉진하고 있습니다. 전반적으로 스캐폴드 기술의 기술 혁신과 조직 공학에 대한 강조는 이 시장의 견고한 성장 잠재력을 지원하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술의 진보
스캐폴드 기술 시장 규모 : 유형별
시장 개요
하이드로겔
상처 치유
3D 바이오프린팅
면역 조절
폴리머 스캐폴드
마이크로 패턴 표면 마이크로플레이트
나노섬유 기반 스캐폴드
스캐폴드 기술 시장 규모 : 소재별
시장 개요
바이오 불활성
생체흡수성
바이오액티브
스캐폴드 기술 시장 규모 : 질환 유형별
시장 개요
정형외과
근골격
척추
암
피부
외피
치과
심장혈관학
신경학
비뇨기과
소화기과·부인과
기타
스캐폴드 기술 시장 규모 : 용도별
시장 개요
줄기세포 요법
재생의료
조직공학
암세포 조사
Drug Discovery
기타
스캐폴드 기술 시장 규모 : 최종 용도별
시장 개요
바이오테크놀러지 및 제약 조직
조사실·연구소
병원과 진단 센터
기타
스캐폴드 기술 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Thermo Fisher Scientific, Inc.(United States)
Merck KGaA(Germany)
Tecan Trading AG(Switzerland)
ReproCELL Inc.(Japan)
3D Biotek LLC(United States)
Becton, Dickinson and Company(United States)
Medtronic plc(Ireland)
Corning Incorporated(United States)
Allergan plc(Ireland)
Sanofi S.A.(France)
Avacta Life Sciences Limited(United Kingdom)
Vericel Corporation(United States)
Akron Biotech(United States)
Molecular Matrix, Inc.(United States)
Matricel GmbH(Germany)
Pelobiotech GmbH(Germany)
Xanofi(United States)
4 titude(United Kingdom)
Tempo Therapeutics(United States)
결론과 권장사항
KSA
영문 목차
영문목차
Global Scaffold Technology Market size was valued at USD 1.98 billion in 2023 and is poised to grow from USD 2.25 billion in 2024 to USD 6.34 billion by 2032, growing at a CAGR of 13.8% during the forecast period (2025-2032).
The scaffold technology market is experiencing significant growth, driven by rising global demand for organ transplants and reconstruction therapies due to an increasing number of patients with critical non-functioning organs. Using tissue engineering and regenerative medicine, scaffolds-often created from polymeric biomaterials-provide essential structural support for cells, facilitating the formation of new tissue. The tissue engineering triad comprises cells, scaffolds, and growth factors, with scaffolds categorized into fibrous, porous, and hydrogel types. The success of scaffolds hinges on crucial factors like biocompatibility, mechanical properties, and biodegradability. Furthermore, heightened R&D investments by biotechnology firms in developing advanced 3D matrices are propelling market advancements. Overall, innovations in scaffold technology and a growing emphasis on tissue engineering underscore this market's robust expansion potential.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Scaffold Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Scaffold Technology Market Segmental Analysis
Global Scaffold Technology Market is segmented by Type, Material, Disease Type, Application, End-Use and region. Based on Type, the market is segmented into Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds. Based on Material, the market is segmented into Bio-inert, Bioresorbable and Bioactive. Based on Disease Type, the market is segmented into Orthopedics, Musculoskeletal, Spine, Cancer, Skin, Integumentary, Dental, Cardiology & Vascular, Neurology, Urology, GI & Gynecology and Others. Based on Application, the market is segmented into Stem Cell Therapy, Regenerative Medicine, Tissue Engineering, Cancer cell research, Drug Discovery and Others. Based on End-Use, the market is segmented into Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Scaffold Technology Market
The Global Scaffold Technology market is significantly influenced by several key drivers, including the advancement of regenerative technologies and their expanding applications. A rise in accidents leading to organ damage is expected to bolster the need for scaffold technology further. Moreover, the growing aging population may pose a challenge to market growth. Nevertheless, the escalating demand for tissue engineering and reconstructive surgeries, the widespread adoption of biomaterials, along with continuous technological innovations in scaffold technology, are the primary factors propelling the market forward. This combination of demand increase and technological development is essential for the market's success and sustainability.
Restraints in the Global Scaffold Technology Market
The Global Scaffold Technology market faces several constraints impacting its revenue growth during the forecast period. Notably, the rise of scaffold-free methodologies for multi-dimensional cell culture, along with the advancement of matrix-based 3D cellular models, has resulted in mixed outcomes. High implementation costs associated with these technologies further hinder market expansion. Additionally, the introduction of scaffold-free cell culture alternatives is likely to pose a challenge to traditional scaffold solutions. However, there exists significant growth potential in emerging nations, particularly if their governments increase investment in research and development, which could drive innovation and market opportunities in the region.
Market Trends of the Global Scaffold Technology Market
The Global Scaffold Technology market is poised for significant growth driven by advances in synthetic scaffold materials, particularly within tissue engineering. Innovations across genetics, pharmaceuticals, and materials science are aligning to enhance the efficacy and applicability of scaffolds in regenerative medicine. This is particularly critical in addressing the disparity between organ supply and demand for transplantation among patients with terminal conditions. As the need for viable organ alternatives escalates, scaffold technology emerges as a pivotal solution, catalyzing market expansion and attracting investment in research and development, ultimately promising improved patient outcomes and healthcare solutions in the coming years.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Global Scaffold Technology Market Size by Type & CAGR (2025-2032)
Market Overview
Hydrogels
Wound Healing
3D Bioprinting
Immunomodulation
Polymeric Scaffolds
Micropatterned Surface Microplates
Nanofiber Based Scaffolds
Global Scaffold Technology Market Size by Material & CAGR (2025-2032)
Market Overview
Bio-inert
Bioresorbable
Bioactive
Global Scaffold Technology Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Orthopedics
Musculoskeletal
Spine
Cancer
Skin
Integumentary
Dental
Cardiology & Vascular
Neurology
Urology
GI & Gynecology
Others
Global Scaffold Technology Market Size by Application & CAGR (2025-2032)
Market Overview
Stem Cell Therapy
Regenerative Medicine
Tissue Engineering
Cancer cell research
Drug Discovery
Others
Global Scaffold Technology Market Size by End-Use & CAGR (2025-2032)
Market Overview
Biotechnology & Pharmaceutical Organizations
Research Laboratories & Institutes
Hospitals & Diagnostic Centers
Others
Global Scaffold Technology Market Size & CAGR (2025-2032)
North America (Type, Material, Disease Type, Application, End-Use)
US
Canada
Europe (Type, Material, Disease Type, Application, End-Use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Material, Disease Type, Application, End-Use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Material, Disease Type, Application, End-Use)
Brazil
Rest of Latin America
Middle East & Africa (Type, Material, Disease Type, Application, End-Use)
